Cargando…

Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients

Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatah, Ernieda, Rahim, Nadiah, Makmor-Bakry, Mohd, Mohamed Shah, Noraida, Mohamad, Noraini, Ahmad, Mahadir, Haron, Nor Hasni, Sze Hwe, Choe, Tan Meng Wah, Angeline, Hassan, Fahmi, Shaik Rahmat, Shakirin, Robert, Sarah Ann, Abdullah, Noraidatulakma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647074/
https://www.ncbi.nlm.nih.gov/pubmed/33157549
http://dx.doi.org/10.1371/journal.pone.0241909
_version_ 1783606882632466432
author Hatah, Ernieda
Rahim, Nadiah
Makmor-Bakry, Mohd
Mohamed Shah, Noraida
Mohamad, Noraini
Ahmad, Mahadir
Haron, Nor Hasni
Sze Hwe, Choe
Tan Meng Wah, Angeline
Hassan, Fahmi
Shaik Rahmat, Shakirin
Robert, Sarah Ann
Abdullah, Noraidatulakma
author_facet Hatah, Ernieda
Rahim, Nadiah
Makmor-Bakry, Mohd
Mohamed Shah, Noraida
Mohamad, Noraini
Ahmad, Mahadir
Haron, Nor Hasni
Sze Hwe, Choe
Tan Meng Wah, Angeline
Hassan, Fahmi
Shaik Rahmat, Shakirin
Robert, Sarah Ann
Abdullah, Noraidatulakma
author_sort Hatah, Ernieda
collection PubMed
description Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical because it requires a license and currently every form used is charged. Hence, there is a need to develop and validate a new medication adherence tool. The Malaysia Medication Adherence Assessment Tool (MyMAAT) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. The face and content validities of the MyMAAT was established by a panel of experts. A total of 495 patients with type 2 diabetes were recruited from the Ministry of Health facilities consisting of five hospitals and five primary health clinics. A test-retest was conducted on 42 of the patients one week following their first data collection. Exploratory factor analysis was performed to evaluate the validity of the MyMAAT. The final item for MyMAAT was compared with SEAMS, HbA(1c)%, Medication Possession ratio (MPR) score, and pharmacist’s subjective assessment for its hypothesis testing validity. The MyMAAT-12 achieved acceptable internal consistency (Cronbach’s alpha = 0.910) and stable reliability as the test-retest score showed good to excellent correlation (Spearman’s rho = 0.96, p = 0.001). The MyMAAT has significant moderate association with SEAMS (Spearman’s rho = 0.44, p = < 0.001) and significant relationship with HbA1c (< 8% and ≥ 8%) (χ(2)(1) = 13.4, p < 0.001), MPR (χ(2)(1) = 13.6, p < 0.001) and pharmacist’s subjective assessment categories (χ(2)(1) = 31, p < 0.001). The sensitivity of MyMAAT-12, tested against HbA1c% was 72.9% while its specificity was 43%. This study demonstrates that the MyMAAT-12 together with other methods of assessment may make a better screening tool to identify patients who were non-adherence to their medications.
format Online
Article
Text
id pubmed-7647074
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-76470742020-11-16 Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients Hatah, Ernieda Rahim, Nadiah Makmor-Bakry, Mohd Mohamed Shah, Noraida Mohamad, Noraini Ahmad, Mahadir Haron, Nor Hasni Sze Hwe, Choe Tan Meng Wah, Angeline Hassan, Fahmi Shaik Rahmat, Shakirin Robert, Sarah Ann Abdullah, Noraidatulakma PLoS One Research Article Medication non-adherence remains a significant barrier in achieving better health outcomes for patients with chronic diseases. Previous self-reported medication adherence tools were not developed in the context of the Malaysia population. The most commonly used tool, MMAS-8, is no longer economical because it requires a license and currently every form used is charged. Hence, there is a need to develop and validate a new medication adherence tool. The Malaysia Medication Adherence Assessment Tool (MyMAAT) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. The face and content validities of the MyMAAT was established by a panel of experts. A total of 495 patients with type 2 diabetes were recruited from the Ministry of Health facilities consisting of five hospitals and five primary health clinics. A test-retest was conducted on 42 of the patients one week following their first data collection. Exploratory factor analysis was performed to evaluate the validity of the MyMAAT. The final item for MyMAAT was compared with SEAMS, HbA(1c)%, Medication Possession ratio (MPR) score, and pharmacist’s subjective assessment for its hypothesis testing validity. The MyMAAT-12 achieved acceptable internal consistency (Cronbach’s alpha = 0.910) and stable reliability as the test-retest score showed good to excellent correlation (Spearman’s rho = 0.96, p = 0.001). The MyMAAT has significant moderate association with SEAMS (Spearman’s rho = 0.44, p = < 0.001) and significant relationship with HbA1c (< 8% and ≥ 8%) (χ(2)(1) = 13.4, p < 0.001), MPR (χ(2)(1) = 13.6, p < 0.001) and pharmacist’s subjective assessment categories (χ(2)(1) = 31, p < 0.001). The sensitivity of MyMAAT-12, tested against HbA1c% was 72.9% while its specificity was 43%. This study demonstrates that the MyMAAT-12 together with other methods of assessment may make a better screening tool to identify patients who were non-adherence to their medications. Public Library of Science 2020-11-06 /pmc/articles/PMC7647074/ /pubmed/33157549 http://dx.doi.org/10.1371/journal.pone.0241909 Text en © 2020 Hatah et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hatah, Ernieda
Rahim, Nadiah
Makmor-Bakry, Mohd
Mohamed Shah, Noraida
Mohamad, Noraini
Ahmad, Mahadir
Haron, Nor Hasni
Sze Hwe, Choe
Tan Meng Wah, Angeline
Hassan, Fahmi
Shaik Rahmat, Shakirin
Robert, Sarah Ann
Abdullah, Noraidatulakma
Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title_full Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title_fullStr Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title_full_unstemmed Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title_short Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients
title_sort development and validation of malaysia medication adherence assessment tool (mymaat) for diabetic patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647074/
https://www.ncbi.nlm.nih.gov/pubmed/33157549
http://dx.doi.org/10.1371/journal.pone.0241909
work_keys_str_mv AT hatahernieda developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT rahimnadiah developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT makmorbakrymohd developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT mohamedshahnoraida developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT mohamadnoraini developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT ahmadmahadir developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT haronnorhasni developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT szehwechoe developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT tanmengwahangeline developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT hassanfahmi developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT shaikrahmatshakirin developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT robertsarahann developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients
AT abdullahnoraidatulakma developmentandvalidationofmalaysiamedicationadherenceassessmenttoolmymaatfordiabeticpatients